Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

UK national multi-centre randomised Phase II clinical trial, that aims to save lives and get an early indication of bemcentinib's effectiveness in treating the most vulnerable patients with COVID-19

Next Previous
Search
Trial Profile

UK national multi-centre randomised Phase II clinical trial, that aims to save lives and get an early indication of bemcentinib's effectiveness in treating the most vulnerable patients with COVID-19

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bemcentinib (Primary)
  • Indications COVID 2019 infections
  • Focus Therapeutic Use
  • Acronyms ACCORD

    • Most Recent Events

    • 28 Jul 2020 According to a BerGenBio media release, incidence of COVID-19 in the UK has drastically reduced in the recent weeks and as a result the ACCORD programme hasn't moved forward as swiftly as we expected.
    • 28 Jul 2020 According to a BerGenBio media release, the UK Research and Innovation's (UKRI) has decided to cease the grant funding to the University Hospital Southampton NHS Trust for this trial and the University Hospital Southampton NHS Trust has notified all sites to cease recruitment of new patients into the trial. The patients already recruited and dosed with bemcentinib, will continue on treatment as per the protocol.
    • 28 Jul 2020 Status changed from recruiting to discontinued, according to a BerGenBio media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top